AlphaQuest’s Filana Therapeutics FLNA Stock Holding History

AlphaQuest’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,026	Closed	-$9.95K	–	1701
2025 Q4	$9.95K	Hold	5,026	–	–	﹤0.01%	2155
2025 Q3	$14.6K	Hold	5,026	–	–	﹤0.01%	2130
2025 Q2	$9.1K	Hold	5,026	–	–	﹤0.01%	1859
2025 Q1	$7.54K	Hold	5,026	–	–	﹤0.01%	1822
2024 Q4	$11.9K	Buy	5,026 +3,029	+152%	+$53.2K	﹤0.01%	1458
2024 Q3	$58.8K	Buy	1,997 +1,080	+118%	+$24.9K	0.01%	1383
2024 Q2	$11.3K	Sell	917 -407	-31%	-$8.58K	﹤0.01%	1319
2024 Q1	$26.9K	Sell	1,324 -3,926	-75%	-$90.5K	﹤0.01%	1003
2023 Q4	$118K	Buy	+5,250	New	+$111K	0.03%	732

Other funds holding FLNA

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AlphaQuest's FLNA Position: Q1 2026 in Review

AlphaQuest sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 5,026 shares — an estimated $9.95K sold.

AlphaQuest first reported a position in FLNA in Q4 2023 and held it in 9 quarters. The position peaked at $118K in Q4 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

AlphaQuest reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 5,026 Filana Therapeutics shares in Q1 2026, an estimated $9.95K.
AlphaQuest first reported a position in Filana Therapeutics in Q4 2023 and held it in 9 quarters.
AlphaQuest's Filana Therapeutics position peaked at $118K in Q4 2023.
101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.